EPCARG
Live / Registered — Registered (as of 07 Apr 2020)
What this means for you
Registered since 07 Apr 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88278778
- Registration number
- 6026619
- Mark type
- Stylized text
- Filed
- 28 Jan 2019
- Published for opposition
- 21 Jan 2020
- Registered
- 07 Apr 2020
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 001 — Chemicals: Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules, biologics, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, cells, microorganisms, protein-based capsids or particles as well as fragments, fractions and derivatives thereof
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; vaccines; pharmaceutical preparations, namely, adjuvants, carriers for active ingredients and drug delivery systems based on an engineered protein capsule for medical use in humans or animals, implants comprising active ingredients for the prevention or treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation; all the aforementioned goods only being either drug delivery agents based on an engineered protein capsule or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned goods for use in connection with the treatment or prevention of hepatitis
- Class 040 — Treatment of materials: Manufacture of pharmaceutical products, medicinal products, medicaments from pharmaceutical compositions for third parties; all the aforementioned only in relation to drug delivery agents or systems based on an engineered protein capsule and/or pharmaceutical products or preparations for use with a drug delivery agent or system based on an engineered protein capsule; none of the aforementioned for use in connection with the treatment or prevention of hepatitis
- Class 042 — Scientific and technological services: Scientific research and development for third parties, in particular in the fields of medicine, pharmacy, diagnostics, chemistry, biology, biochemistry and biotechnology; scientific research and development with regard to the manufacture of pharmaceutical preparations, carriers for active ingredients and drug delivery systems for use in humans or animals, for third parties; development of pharmaceutical preparations, namely, medical products for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination or immunostimmulation, for third parties
Owner
- NEUWAY Pharma GmbH, Bonn, DE
- NEUWAY Pharma GmbH, Bonn, DE
- NEUWAY Pharma GmbH, Bonn, DE
Prosecution history
- 07 Apr 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Apr 2020 — REGISTERED-PRINCIPAL REGISTER
- 21 Jan 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2020 — PUBLISHED FOR OPPOSITION
- 01 Jan 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Dec 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Dec 2019 — EXAMINER'S AMENDMENT ENTERED
- 16 Dec 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 16 Dec 2019 — EXAMINERS AMENDMENT E-MAILED
- 16 Dec 2019 — EXAMINERS AMENDMENT -WRITTEN